Products and Services

Products and Services

PRODUCTS AND SERVICES NEW PRODUCTS AND SERVICES CONSIDERED TO BE OF IN. terest to our readers are described on the basis of information supplied by t...

642KB Sizes 1 Downloads 78 Views

PRODUCTS AND SERVICES NEW PRODUCTS AND SERVICES CONSIDERED TO BE OF IN.

terest to our readers are described on the basis of information supplied by the companies cited. Publication of these notices does not imply endorsement or warranty by The Ophthalmic Publishing Company, publishers of the AMERICAN JOURNAL OF OPHTHALMOLOGY, for these products and services.

SURGICAL INSTRUMENTS

• Visitec Company, 7575 Commerce Court, Sarasota, FLA 34243; telephone: (800) 237-2174 or (940 359-9883; fax: (800) 705-2525 Visitec Company introduces the 5216 LASIK Flap Irrigator (Vidaurri), which features two parallel .50 x 13-mm tip extensions angled 45 degrees and placed 1 mm apart. Each extension possesses four ports, two inside and two outside. The universal cannula simultaneously irrigates both sides of the LASIK flap, washes out the stromal bed, and enables flap repositioning.

Visitec Company also announces the extension of the range of its portable Visitrec Vitrectomy System with the addition of the 5215 Visitrec Vitreous Biopsy Probe 00sephberg). The new probe provides one-step paracentesis, cutting, and aspiration with a single instrument. The 20-g guillotine cutting probe tapers to 23 gat 13.5 mm from the tip, providing a guide to determine how far the probe has been inserted. The MVR tip is .75 mm, and the aspiration port is .5 mm, The aspiration port is aligned with the blade edge for atraumatic insertion. The aspiration tube of the hub indicates the orientation of both the aspiration port and the blade edge. No suturing is required because the MVR tip makes a small sclerotomy. The cutter automatically stops in the open position for atraumatic removal through the sclerotomy. Visitec Company also presents two new entries to its line of EdgeAhead Ophthalmic Surgical Knives series. The 1140 EdgeAhead IOL Knife 3.5 mm straight and 1141 EdgeAhead IOL Knife 3.5 mm angled satisfy the surgeon's needs for a smaller IOL incision. All EdgeAhead Knives feature a precise, sharp cutting edge for a clean incision and reduced tissue distortion and have a nonglare matte finish to minimize reflection from microscope light.

DIAGNOSTIC INSTRUMENTS

• Keeler Instruments Inc, 456 Parkway, Broomall, PA 19008; telephone: (800) 523-5620 or (610) 353-4350; fax: 610 353-7814 Keeler announces that the diffuser on the Keeler Vantage Indirect Ophthalmoscope is now nearly three times brighter. The diffuser's new material provides this improvement without compromising the Keeler Van­ tage's ability to provide up to 50% enlargement of the illuminated field. The diffuser was engineered to allow the user a significantly grosser margin of error during the most difficult retinal exams. It expands the illuminated field up to 50%, even in the peripherary of undilated eyes, greatly relaxing the normally critical alignment between the headset, condensing lens, and pupil in order to achieve a full lens image. This more forgiving alignment ensures greater ease in maintaining a view under situations that are often compromised, such as when examining noncompliant patients or children; when viewing through undilated eyes; and when viewing the periphary of both dilated and undilated eyes. The new diffuser is an integrated feature on the Keeler Vantage and can be used with the yellow safety, red-free, and cobalt blue filters.

operation and assures consistent, accurate reading without a joystick. Designed on a 32-bit platform, the CT 200 produces color maps in less than 4 seconds, many times faster than other current models.

SURGICAL ACCESSORIES • FCI Ophthalmics, P.O. Box 465, Marshfield Hills, MA 02051; telephone: (800) 932-4202; fax: (617) 837-8292; e-mail: [email protected] FCI Ophthalmics, Inc, introduces to the American market its internationally established line of implants for retinal detachment surgery. All scleral buckling components, including bands, sleeves, strips, tires, and sponges, are made of soft elastic medicalgrade silicone and are available for immediate delivery.

MAGNIFIERS

• Dicon, 10373 Roselle St, San Diego, CA 92121; telephone: (800) 426-0493 or (619) 554-1770; fax: (619) 554-0332 For corneal topography, Dicon intro­ duces the CT 200. This corneal topographer features automatic self-align and self-focus systems for ease of

• Eschenbach, 904 Ethan Allen Highway, Ridgefield, CT 06877; telephone: (203) 438-7471; fax: (203) 438-1670 Eschenbach introduces an innovative series of frameless aspheric hand-held magnifiers. Light enough to be held for extended periods of time, the Slim-Line magnifiers allow for comfortable binocular use, even at powers as high as 14 diopters. The unique frameless edge acts like a typoscope to aid with reading. The 90 x 25-mm lens spans a column of newsprint and is scratch-resistant and antistatic coated. This new magnifier is small enough to be put in a pocket or purse and can be taken anywhere. Three powers are available: 6D, 10D, and 14D. Each magnifier comes with a protective case.

EDUCATIONAL VIDEOTAPES

• Alcon Surgical, Inc, 6201 S Freeway, Fort Worth, TX 76134; telephone: (800) 862-5266; fax: (817) 5514533 Alcon announces the availability of several new vitreoretinal educational videotapes. Alcon's Videotape Library offers educational videotapes featuring prominent physicians utilizing up-to-date techniques and treatments in a variety of ophthalmic procedures. Several new videos focusing on vitreoretinal procedures have recently been added. The tapes are loaned for 21 days at no charge. After the tapes have been viewed, they can be returned by means of a postage-paid label, which is included. Tapes may also be purchased. Newly avalable titles include: Basic Vitrec­ tomy Techniques for Macular Holes; Basic Vitrectomy Tech­ niques for Diabetic Retinopathy; An Intraocular Look at Vitreous Surgery; and Lens Sparing Vitrectomy in Children.

SOFTWARE

• Voice Activated Systems Technologies, Inc, 2455 Bennett Valley Rd, Santa Rosa, CA 95404; telephone: (707) 573-8800; fax: (707 573-8980; e-mail: [email protected] Voice Activiated Systems Techno­ logies, Inc (VAST), announces new versions of its PCbased medical continuous speech recognition software, Express Note Taker and VAST.NET. Express Note Taker is a core software product module used by individual physi­ cians in their office or hospital environments. It uses diagnosis-based, customizable forms to allow physicians hands-free dictation of progress notes, referral letters, prescriptions, and reports. VA.ST.NET is a client/serverbased interface network that connects individual Express stations to a hospital's medical information system. All documents created contain structured, coded information that can be accessed by a database. Used together, the two programs create a comprehensive electronic medical re­ cords input/output technology solution that addresses ex­ isting cost and quality problems.

CD-ROM

• Dicon, 10373 Roselle St, San Diego, CA 92121; telephone: (800) 426-0493 or (619) 554-1770; fax: (619) 554-0332 Dicon announces the release of their interactive CD-ROM Visual Fields: Pathways to Interpreta­ tion. The CD-ROM is an interactive guide to correlating fields, fundus, and neuro-imaging. It is authored by Jerome Sherman, OD, Ivan Bodis-Wollner, MD, Alfredo Sadun, MD, PhD, and Ron Banfiel with Lawrence Yannuzzi, MD, as a contributing author, and with a foreword by Harry Quigley, MD. The interactive format allows the CD to be used in a didactic manner. The material is divided into chapters and includes 48 fully interactive case history studies. The reader can see magnified images or patient histories at the click of a mouse and can learn by answering questions. The Interactive Visual Pathway model is also able to correlate any visual field defect to a specific part of the visual pathway. The CD is priced at $159.00 and is available exclusively from Dicon.

EYEWEAR

• Essilor of America, Inc, 2400 118th Ave N, St Petersburg, FL 33716; telephone: (813) 572-0844 Essilor of America announces the introduction of Ormex® in Essilor Natural™ and semi-finished single-vision (SFSV) lenses. Ormex, with a 1.55 index of refraction, is up to 23% thinner and 28% lighter than standard hardresin lenses. Additionally, Ormex does not require back­ side coating, and it includes 99.7% UVA and 100% UVB block as well as UltraShield,® the most scratch-resistant coating available today. Ormex is available in Essilor's advanced progressive and single-vision aspheric lens de­ signs.

AMERICAN JOURNAL OF OPHTHALMOLOGY® OPHTHALMIC PUBLISHING COMPANY

77 W. Wacker Dr., Suite 660, Chicago, IL 60601-1632 USA DISCLOSURE STATEMENT AND COPYRIGHT TRANSFER Authors who submit Original Articles, Brief Reports, Editorials, and Perspectives must include the following Copyright Transfer and Disclosure Statement, published in each issue of T H E JOURNAL. The form must be signed by all authors, including the corresponding author. Each signature must be original; faxed and photocopied signatures cannot be accepted. It is not necessary that all signatures be on the same form; as many copies of this form may be used as convenient. United States government employees are to include the following statement, in addition to the Disclosure Statement and Copyright Transfer: The manuscript, including figures and tables, referred to in this Disclosure Statement and Copyright Transfer is a work of authorship prepared as part of the undersigned author's (or authors') official duties as an officer or employee of the United States Government and is therefore in the public domain. Should the manuscript ever be determined to be copyrightable, I (or we) hereby transfer, assign, or otherwise convey all copyright ownership in the above named manuscript to the AMERICAN JOURNAL OF OPHTHALMOLOGY.

DISCLOSURE STATEMENT The enclosed typescript, figures, and tables are submitted solely to the AMERICAN JOURNAL OF OPHTHALMOLOGY. The undersigned confirm that the written narration, the data, and the figures have not been previously published, have not been simultaneously submitted for publication elsewhere, will not be submitted elsewhere for publication while this work is under consideration, and are not subject to copyright or other rights except those of the authors. The authors further confirm that variations of the narration, variations of the data, variations of the figures, or variations of interpretation have not been submitted elsewhere for publication and will not be submitted elsewhere for publication while this work is under consideration by or, if accepted, before its publication in the AMERICAN JOURNAL OF OPHTHALMOLOGY. Additionally, this material has not been and will not be the topic of news interviews or press releases. The authors further confirm that the narration, the figures, and the data, or variations thereof, have not been the topic of distribution by auditory or visual reproduction. The authors further confirm that these materials have not been the topic of a lecture, a radio or television broadcast, or a poster exhibit, except as indicated. The authors further confirm that the narration or portions of it, the data or portions of them, and the figures, have been presented at scientific meetings only as indicated. The authors of this study confirm that each has contributed significantly to the formulation or execution of the study or to the writing of the paper herein submitted. The authors further confirm that they have read and concur in the writing and conclusion of the typescript, data, and figures submitted hereinComplete disclosure of any proprietary interests, such as patent rights, commercial financial support, commercial consultation fees, or related equity ownership, is provided in a separate statement.

COPYRIGHT TRANSFER This signed copyright transfer confirms that each part of this work, including the text, the figures, the tables, the data, and the references, has been submitted solely to the AMERICAN JOURNAL OF OPHTHALMOLOGY. The undersigned author or authors hereby transfer to the AMERICAN JOURNAL OF OPHTHALMOLOGY all worldwide rights, title, and interest to all parts of the written work named below, including the following: (1) copyright, (2) the right to grant permission to republish in whole or part with or without fee, (3) the right to produce reprints or preprints for sale or for free distribution, and (4) the right to republish the work in a collection of articles in any other format. The authors further affirm that the work has not been previously published and is not subject to copyright or other rights.

AUTHORS' NAMES MUST BE LISTED IN THE ORDER GIVEN ON THE TITLE PAGE OF THE MANUSCRIPT. Each signature must be original; faxed and photocopied signatures cannot be accepted. TITLE:

CORRESPONDING AUTHOR:

Name (print):

Signature:

Date: _

Address: Telephone:

(

)

Fax:

(

)

E-mail:

1. Name (print): Signature:

Date:

2. Name (print): Signature:

Date:

3. Name (print): Signature:

Date: To accommodate additional authors, copies of this transfer may be made as necessary.